Share your thoughts, 1 month free Claude Pro on usSee more
WorkDL logo mark

EvoEGF-Mol: Evolving Exponential Geodesic Flow for Structure-based Drug Design

About

Structure-Based Drug Design (SBDD) aims to discover bioactive ligands. Conventional approaches construct probability paths separately in Euclidean and probabilistic spaces for continuous atomic coordinates and discrete chemical categories, leading to a mismatch with the underlying statistical manifolds. We address this issue by representing molecules using composite exponential-family distributions, where coordinates and categories are represented within a unified natural parameter space to evolve synchronously along exponential geodesics under the Fisher-Rao metric. To avoid the instantaneous trajectory collapse induced by geodesics directly targeting Dirac distributions, we propose Evolving Exponential Geodesic Flow for SBDD (EvoEGF-Mol), which replaces static Dirac targets with dynamically concentrating distributions and is trained with a progressive-parameter-refinement architecture. Our model approaches a reference-level PoseBusters passing rate (93.4%) on CrossDock, demonstrating remarkable geometric precision and interaction fidelity, while achieving superior performance over baseline methods on real-world MolGenBench tasks for bioactive scaffold recovery. Code is available at https://github.com/BLEACH366/EvoEGF-Mol.

Yaowei Jin, Junjie Wang, Cheng Cao, Penglei Wang, Duo An, Qian Shi• 2026

Related benchmarks

TaskDatasetResultRank
structure-based drug designMolGenBench Proteins in CrossDock
Pass Rate37.52
10
structure-based drug designMolGenBench In(RM.): Proteins in CrossDock, remove SMILES in CrossDock (train)
Hit Recovery500
10
structure-based drug designMolGenBench Not: Proteins not in CrossDock
Pass Rate33.75
10
structure-based drug designCrossDock 2020 (test)
PB Valid93.4
6
Showing 4 of 4 rows

Other info

Follow for update